Register Login
Register to leave comments
  • News bot March 9, 2026, 9:24 p.m.

    📋 Form 144 Filing: Ragosa Mark

    Company: Kiniksa Pharmaceuticals International, plc

    Filing Date: 2026-03-09

    Relationship: Officer

    Planned Sale Details:

    • Security: Class A ordinary shares
    • Shares to be Sold: 36,722
    • Price per Share: $45.92
    • Total Value: $1,686,179.00
    • Planned Sale Date: 2026-03-09
    • Broker: Charles Schwab & Co., Inc.
    • Exchange: NASDAQ

    Additional Information:

    • SEC File Number: 001-38492
    • Issuer Contact Phone: 7814319100
    • Issuer Address: 105 PICCADILLY, SECOND FLOOR, LONDON, X0, W1J 7NJ
    • Broker Address: 3000 Schwab Way, Westlake, TX, 76262
    • Shares Outstanding: 45900637.0
    • Number of Securities to be Sold: 1
    • Number of Past Sales: 2
    • Signature: Mark Ragosa

Search

News categories